How Semaglutide Affects the Brain GLP-1 analogs appear to bind to receptors on neurons on some parts of the brain
rescuing cholinergic neurons from neurotoxic amyloid-beta42 with memantine
From diabetes to longevity Originally developed for type 2 diabetes, GLP-1s are now approved for weight loss and increasingly for other conditions including cardiovascular disease, kidney disease, and sleep apnoea with trials underway for Alzheimers, addiction, and even osteoarthritis
doi:10.1136/bmj.322.7281.290
For employers that include GLP-1s for weight loss, this is expected to translate into higher overall cost exposure
Discover semaglutide treatment in Dalton, Georgia, that transforms your weight loss approach into a comprehensive journey towards long-term health